Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture

Summary

Prospective, unicenter, randomized, open-label, single-dose, two-arms blinded assessor pilot study. Thirty-two (32) elderly patients with hip fracture will be randomized to one of the two treatment-arms (Xcel-MT-osteo-beta or Standard treatment) and be followed for 12 month with the primary objective of safety. Secondary objectives are efficacy through axial tomography and xRay, clinical efficacy and quality of life questionnaire.

Timeline

Start

2015-12

Primary completion

2017-12

Completion

2018-12

Drugs

Indications